Clinical Trial Update: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pertuzumab in combination with carboplatin-based chemotherapy for recurrent ovarian cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pertuzumab (pertuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-12-04